Eastern Canadian Colorectal Cancer Consensus Conference 2017

Current oncology

A. Hyde¹  S. Kanagaratnam²  D. Bossé³  A. Jeyakumar⁴  C. Booth⁵  S. Berry⁶  M. Harb⁷  W. AlGhareeb⁸  S. Gray⁹  A. MacMillan^1,10  D. Jonker^1,11  A. Muinuddin^1,12  P. Kavan^1,13  R. Goel^1,14  B. Colwell^1,15  N. Finn^1,16  J. Biagi^1,17  J. Green^1,18  S. Babak^1,19  P. Champion^2,20  C.H. Ahmad^2,21  S.F. McGee^2,22  D. Armstrong^2,23 

[1] Memorial University of Newfoundland;Centre hospitalier de l’Université de Montréal;Centre hospitalier universitaire Dr-Georges-L.-Dumont;Colorectal Cancer Canada;Dalhousie University;Dana–Farber Cancer Institute;Dr. Everett Chalmers Hospital;Dr. H. Bliss Murphy Cancer Centre;Eastern Health Authority;Grand River Regional Cancer Centre;Grenfell Regional Health Authority;London Health Sciences Centre;McGill University Health Centr;McGill University Health Centre;Memorial University of Newfoundland;Moncton City Hospital;Prince Edward Island Cancer Treatment Centre;Queensway Health Centre;Queen’s University and Cancer Centre of Southeastern Ontario;Saint John Regional Hospital;St. Michael’s Hospital;The Ottawa Hospital Cancer Centre;University of Toronto

关键词: Guidelines;    gastric cancer;    colorectal cancer;    rectal cancer;    peritoneal carcinomatosis;    chemotherapy;    radiation therapy;    immunotherapy;    molecular markers;    hereditary cancer syndromes;   

DOI  :  10.3747/co.25.4083

学科分类：肿瘤学

来源: Multimed, Inc.

【 摘 要 】

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2017 was held in St. John’s, Newfoundland and Labrador, 28–30 September. Experts in radiation oncology, medical oncology, surgical oncology, and cancer genetics who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of gastric, rectal, and colon cancer, including identification and management of hereditary gastric and colorectal cancer (crc);palliative systemic therapy for metastatic gastric cancer;optimum duration of preoperative radiation in rectal cancer—that is, short- compared with long-course radiation;management options for peritoneal carcinomatosis in crc;implications of tumour location for treatment and prognosis in crc; andnew molecular markers in crc.

【 授权许可】

Unknown